Sex hormones and mood in the perimenopause

Annals of the New York Academy of Sciences

Volumn 1179, Issue , 2009, Pages 70-85

  Schmidt, Peter J ^a   Rubinow, David R ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Estrogen; Menopause transition

Indexed keywords

ANDROSTENEDIONE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ESTRADIOL; ESTROGEN; FOLLITROPIN; GLUCOCORTICOID RECEPTOR; GONADORELIN AGONIST; GONADOTROPIN; LUTEINIZING HORMONE; NORADRENALIN UPTAKE INHIBITOR; PRASTERONE; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE; TESTOSTERONE;

CENTRAL NERVOUS SYSTEM; CLIMACTERIUM; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; ESTROGEN SYNTHESIS; ESTROGEN THERAPY; FOLLITROPIN BLOOD LEVEL; FOLLITROPIN RELEASE; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INVOLUTIONAL DEPRESSION; LUTEINIZING HORMONE RELEASE; MOOD; NONHUMAN; TRANQUILIZING ACTIVITY; TREATMENT DURATION;

CROSS-SECTIONAL STUDIES; DEPRESSION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PERIMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 70449410348     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04982.x     Document Type: Conference Paper

References (169)

1. Soules, M.R., S. Sherman, E. Parrott, et al. 2001. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil. Steril. 76: 874-878. (Pubitemid 33031310)
2. Santoro, N., J.R. Brown, T. Adel, et al. 1996. Characterization of reproductive hormonal dynamics in the perimenopause. J. Clin. Endocrinol. Metab. 81: 1495-1501.
3. Treloar, A.E. 1981. Menstrual cyclicity and the premenopause. Maturitas 3: 249-264.
4. Richardson, S.J. 1993. The biological basis of the menopause Baillieres. Clin. Endocrinol. Metab. 7: 1-16.
5. Miro, F., S.W. Parker, L.J. Aspinall, et al. 2004. Relationship between follicle-stimulating hormone levels at the beginning of the human menstrual cycle, length of the follicular phase and excreted estrogens: The FREEDOM study. J. Clin. Endocrinol. Metab. 89: 3270-3275.
6. Klein,N.A., A.J. Harper, B.S.Houmard, et al. 2002. Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development? J. Clin. Endocrinol. Metab. 87: 5746-5750.
7. Hall, J.E. 2007. Neuroendocrine changes with reproductive aging in women. Semin. Repro. Med. 25: 344-351.
8. Hall, J.E. 2004. Neuroendocrine physiology of the early and late menopause. Endocrinol. Metab. Clin. North Am. 33: 637-659.
9. Welt, C.K., Y. Jimenez, P.M. Sluss, et al. 2006. Control of estradiol secretion in reproductive ageing. Hum. Reprod. 21: 2189-2193.
10. Burger,H.G., E.C. Dudley, J.L. Hopper, et al. 1995. The endocrinology of the menopausal transition: A cross-sectional study of a population-based sample. J. Clin. Endocrinol. Metab. 80: 3537-3545.
11. Hale, G.E., X. Zhao, C.L. Hughes, et al. 2007. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the staging of reproductive aging workshop (STRAW) staging system. J. Clin. Endocrinol. Metab. 92: 3060-3067.
12. Freeman, E.W., M.D. Sammel, C.R. Gracia, et al. 2005. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil. Steril. 83: 383-392.
13. Couzinet, B., G. Meduri, M.G. Lecce, et al. 2001. The postmenopausal ovary is not amajor androgenproducing gland. J. Clin. Endocrinol. Metab. 86: 5060-5066.
14. Davison, S.L., S. Donath, J.G. Montalto, et al. 2005. Androgen levels in adult females: Changes with age, menopause and oophorectomy. J. Clin. Endocrinol. Metab. 90: 3847-3853.
15. Fogle, R.H., F.Z. Stanczyk, X. Zhang, et al. 2007. Ovarian androgen production in postmenopausal women. J. Clin. Endocrinol. Metab. 92: 3040-3043. (Pubitemid 47236368)
16. Chen, J., M.R. Sowers, F.M. Moran, et al. 2006. Circulating bioactive androgens in midlife women. J. Clin. Endocrinol. Metab. 91: 4387-4394.
17. Woolley, C.S. & P.A. Schwartzkroin. 1998. Hormonal effects on the brain. Epilepsia 39: S2-S8.
18. McEwen, B.S., S.E. Alves, K. Bulloch, et al. 1997. Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48(Suppl 7): S8-S15.
19. Rachman, I.M., J.R. Unnerstall, D.W. Pfaff, et al. 1998. Estrogen alters behavior and forebrain cfos expression in ovariectomized rats subjected to the forced swim test. Proc. Natl. Acad. Sci. USA 95: 13941-13946.
20. Rubinow, D.R., P.J. Schmidt & C.A. Roca. 1998. Estrogen-serotonin interactions: Implications for affective regulation. Biol. Psychiatry 44: 839-850.
21. Pecins-Thompson, M., N.A. Brown & C.L. Bethea. 1998. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res. Mol. Brain Res. 53: 120-129.
22. Sumner, B.E.H., K.E. Grant, R. Rosie, et al. 1999. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine2A receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Mol. Brain Res. 73: 119-128.
23. Fink, G. & B.E.H. Sumner. 1996. Oestrogen and mental state. Nature 383: 306.
24. McQueen, J.K., H. Wilson, R.C. Dow, et al. 1996. Oestradiol-17â increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain. J. Physiol. 495: 114P.
25. Bethea, C.L., N.Z. Lu, C. Gundlah, et al. 2002. Diverse actions of ovarian steroids in the serotonin neural system. Front. Neuroendocrinol. 23: 41-100.
26. Sumner,B.E.H.&G. Fink. 1995. Estrogen increases the density of 5-hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat. J. Steroid Biochem. Mol. Biol. 54: 15-20.
27. Sumner, B.E.H. & G. Fink. 1993. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol. Cell. Neurosci. 4: 83-92.
28. 28. Kendall, D.A., G.M. Stancel & S.J. Enna. 1981. Imipramine: Effect of ovarian steroids on modifications in serotonin receptor binding. Science 211: 1183-1185.
29. Le Saux,M. & Di Paolo. 2005. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: Comparison with tamoxifen and raloxifene. J. Psychiatry Neurosci. 30: 110-117.
30. Wissink, S., B. Van Der Burg, B.S. Katzenellenbogen, et al. 2001. Synergistic activation of the serotonin-1A receptor by nuclear factor-kappaB and estrogen. Mol. Endocrinol. 15: 543-552.
31. Bethea, C.L., S.J. Mirkes, A. Su, et al. 2002. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques. Psychoneuroendocrinology 27: 431-445.
32. Gundlah, C.,M. Pecins-Thompson,W.E. Schutzer, et al. 1999. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macqaque hypothalamus. Mol. Brain Res. 63: 325-339.
33. McEwen, B.S. & S.E. Alves. 1999. Estrogen actions in the central nervous system. Endocr. Rev. 20: 279-307.
34. Osterlund, M.K., C. Halldin&Y.L.Hurd. 2000. Effects of chronic 17â-estradiol treatment on the serotonin 5-HT1A receptor mRNA and binding levels in the rat brain. Synapse 35: 39-44.
35. Krezel, W., S. Dupont, A. Krust, et al. 2001. Increased anxiety and synaptic plasticity in estrogen receptor beta-deficient mice. Proc. Natl. Acad. Sci. USA 98: 12278-12282.
36. Lu, N.Z. & C.L. Bethea. 2002. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27: 12-24.
37. Hery, M., D. Becquet, A.M. Francois-Bellan, et al. 1995. Stimulatory effects of 5HT1A receptor agonists on luteinizing hormone-releasing hormone release from cultured fetal rat hypothalamic cells: Interactions with progesterone. Neuroendocrinology 61: 11-18.
38. Maswood, S.,G. Stewart & L. Uphouse. 1995. Gender and estrous cycle effects of the 5-HT1A agonist, 8-OH-DPAT, on hypothalamic serotonin. Pharmacol. Biochem. Behav. 51: 807-813.
39. Clarke, W.P. & S. Maayani. 1990. Estrogen effects on 5-HT1A receptors in hippocampal membranes from ovariectomized rats: Functional and binding studies. Brain Res. 518: 287-291.
40. Thomas,M.L.,D.A. Bland, C.H. Clarke, et al. 1997. Estrogen regulation of serotonin (5-HT) transporter and 5-HT1A receptor mRNA in female rat brain. Abstr. Soc. Neurosci. 23: 1501.
41. Su, T.-P., P.J. Schmidt, M. Danaceau, et al. 1997. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J. Clin. Endocrinol. Metab. 82: 1220-1228.
42. Dinan, T.G., S. Barry, L.N. Yatham, et al. 1990. The reproducibility of the prolactin response to buspirone: Relationship to the menstrual cycle. Int. Clin. Psychopharmacol. 5: 119-123.
43. Bancroft, J., A. Cook, D. Davidson, et al. 1991. Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol. Med. 21: 305-312.
44. O'Keane, V., M. O'Hanlon, M. Webb, et al. 1991. d-Fenfluramine/prolactin response throughout the menstrual cycle: Evidence for an oestrogen-induced alteration. Clin. Endocrinol. 34: 289-292.
45. Schmidt, P.J., J. Raju, M. Danaceau, et al. 2002. The effects of gender and gonadal steroids on the neuroendocrine and temperature response to m- Chlorophenylpiperazine in leuprolide-induced hypogonadism in women and men. Neuropsychopharmacology 27: 800-812.
46. Drevets, W.C. 1999. Prefrontal cortical-amygdalar metabolism in major depression. Ann. N. Y. Acad. Sci. 877: 614-637.
47. Drevets,W.C.,M.E. Thase, E.L.Moses-Kolko, et al. 2007. Serotonin-1A receptor imaging in recurrent depression: Replication and literature review. Nucl. Med. Biol. 34: 865-877.
48. Sargent, P.A., K.H. Kjaer, C.J. Bench, et al. 2000. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY- 100635: Effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 57: 174-180.
49. Parsey, R.V., M.A. Oquendo, R.T. Ogden, et al. 2006. Altered serotonin 1A binding inmajor depression: A [carbonyl-C-11]WAY100635 positron emission tomography study. Biol. Psychiatry 59: 106-113.
50. Jovanovic, H., J. Lundberg, P. Karlsson, et al. 2008. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage 39: 1408-1419.
51. Jovanovic, H., A. Cerin, P. Karlsson, et al. 2006. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiat. Res-Neuroim. 148: 185-193.
52. Moses, E.L., W.C. Drevets, G. Smith, et al. 2000. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: A PET study. Biol. Psychiatry 48: 854-860.
53. Svenningsson, P., E.T. Tzavara, H. Qi, et al. 2007. Biochemical and behavioral evidence for antidepressant- like effects of 5-HT6 receptor stimulation. J. Neurosci. 27: 4201-4209.
54. 54. Svenningsson, P.,K.Chergui, I. Rachleff, et al. 2006. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311: 77-80.
55. Nestler, E.J., R.Z. Terwilliger & R.S. Duman. 1989. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53: 1644-1647.
56. Duman, R.S., G.R. Heninger & E.J. Nestler. 1997. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54: 597-606.
57. Nibuya, M., E.J. Nestler & R.S. Duman. 1996. Chronic antidepressant administration increases the expression of cAMP response element-binding protein (CREB) in rat hippocampus. J. Neurosci. 16: 2365-2372.
58. Sohrabji, F., R.C.Miranda & C.D. Toran-Allerand. 1994. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J. Neurosci. 14: 459-471.
59. Zhou, Y., J.J.Watters &D.M.Dorsa. 1996. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137: 2163-2166.
60. Sohrabji, F., L.A.Greene, R.C. Miranda, et al. 1994. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J. Neurobiol. 25: 974-988.
61. Cardona-Gomez, P., M. Perez, J. Avila, et al. 2004. Estradiol inhibitsGSK3 and regulates interaction of estrogen receptors, GSK3 and beta-catenin in the hippocampus. Mol. Cell. Neurosci. 25: 363-373.
62. Murphy, D.D., N.B. Cole & M. Segal. 1998. Brainderived neurotrophic factor mediates estradiolinduced dendritic spine formation in hippocampal neurons. Proc. Natl. Acad. Sci. USA 95: 11412-11417.
63. Berman, K.F., P.J. Schmidt, D.R. Rubinow, et al. 1997. Modulation of cognition-specific cortical activity by gonadal steroids: A positron-emission tomography study in women. Proc. Natl. Acad. Sci. USA 94: 8836-8841.
64. Shaywitz, S.E., B.A. Shaywitz, K.R. Pugh, et al. 1999. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 281: 1197-1202.
65. Craig, M.C., P.C. Fletcher, E.M. Daly, et al. 2007. Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology 32: 1116-1127.
66. Protopopescu, X., H. Pan, M. Altemus, et al. 2005. Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc. Natl. Acad. Sci. USA 102: 16060-16065.
67. Goldstein, J.M., M. Jerram, R. Poldrack, et al. 2005. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J. Neurosci. 25: 9309-9316.
68. Dreher, J., P.J. Schmidt, P. Kohn, et al. 2007. Menstrual cycle phase modulates reward-related neural function in women. Proc. Natl. Acad. Sci. USA 104: 2465-2470.
69. Redei, E., L. Li, I. Halasz, et al. 1994. Fast glucocorticoid feedback inhibition of ACTH secretion in the ovariectomized rat: Effect of chronic estrogen and progesterone. Neuroendocrinology 60: 113-123.
70. Young, E.A., M. Altemus, V. Parkinson, et al. 2001. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 25: 881-891.
71. Dayas, C.V., Y. Xu, K.M. Buller, et al. 2000. Effects of chronic oestrogen replacement on stress-induced activation of hypothalamic-pituitary- adrenal axis control pathways. J. Neuroendocrinol. 12: 784-794.
72. Komesaroff, P.A., M. Esler, I.J. Clarke, et al. 1998. Effects of estrogen and estrous cycle on glucocorticoid and catecholamine responses to stress in sheep. Am. J. Physiol. 275: E671-E678.
73. Burgess, L.H. & R.J. Handa. 1992. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion and glucocorticoid receptor-mediated functions in female rats. Endocrinology 131: 1261-1269.
74. Carey,M.P., C.H. Deterd, J. de Koning, et al. 1995. The influence of ovarian steroids on hypothalamicpituitary- adrenal regulation in the female rat. J. Endocrinol. 144: 311-321.
75. Viau, V. & M.J. Meaney. 1991. Variations in the hypothalamic- pituitary-adrenal response to stress during the estrous cycle in the rat. Endocrinology 129: 2503-2511.
76. Peiffer, A., M.C. Morale, N. Barden, et al. 1994. Modulation of glucocorticoid receptor gene expression in the thymus by the sex steroid hormonemilieu and correlation with sexual dimorphism of immune response. Endocr. J. 2: 181-192.
77. Peiffer, A.&N.Barden. 1988. Glucocorticoid receptor gene expresion in rat pituitary gland intermediate lobe following ovariectomy. Mol. Cell. Endocrinol. 55: 115-120.
78. Pfeiffer, A. & N. Barden. 1987. Estrogen-induced decrease of glucocorticoid receptor messenger ribonucleic acid concentration in rat anterior pituitary gland. Mol. Endocrinol. 1: 435-440.
79. Piroli, G., C. Grillo, M. Ferrini, et al. 1993. Restoration by bromocriptine of glucocorticoid receptors and glucocorticoid negative feedback on prolactin secretion in estrogen-induced pituitary tumors. Neuroendocrinology 58: 273-279.
80. Biegon, A., A. Reches, L. Snyder, et al. 1983. Serotonergic and noradrenergic receptors in the rat brain: Modulation by chronic exposure to ovarian hormones. Life Sci. 32: 2015-2021.
81. Clarke,W.P.&J. Goldfarb. 1989. Estrogen enhances a 5-HT1A response in hippocampal slices from female rats. Eur. J. Pharmacol. 160: 195-197.
82. Fuller, R.W. 1992. The involvement of serotonin in regulation of pituitary-adrenocortical function. Front. Neuroendocrinol. 13: 250-270.
83. Ankenbauer, W., U. Strahle & G. Schutz. 1988. Synergistic action of glucocorticoid and estradiol responsive elements. Proc. Natl. Acad. Sci. USA 85: 7526-7530.
84. Uht, R.M., C.M. Anderson, P. Webb, et al. 1997. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology 138: 2900-2908.
85. Uht, R., C.M. Anderson, P. Webb, et al. 1998. Steroid hormone interactions at the AP-1 site. Abstracts of the 1998 American Neuroendocrine Society 29.
86. Marinari, K.T., A.I. Leschner & M.P. Doyle. 1976. Menstrual cycle status and adrenocortical reactivity to psychological stress. Psychoneuroendocrinology 1: 213.
87. Kirschbaum, C., B.M. Kudielka, J. Gaab, et al. 1999. Impact of gender, menstrual cycle phase and oral contraceptives on the activity of the hypothalamic-pituitary-adrenal axis. Psychosom. Med. 61: 154-162.
88. Collins, A., P. Eneroth & B. Landgren. 1985. Psychoneuroendocrine stress responses and mood as related to the menstrual cycle. Psychosom. Med. 47: 512-527.
89. Ablanalp, J.M., L. Livingston, R.M. Rose, et al. 1977. Cortisol and growth hormone responses to psychological stress during the menstrual cycle. Psychosom. Med. 39: 158-177.
90. Long, T.D., V.L. Ellingrod, R.G. Kathol, et al. 2000. Lack of menstrual cycle effects on hypothalamicpituitary- adrenal axis response to insulin-induced hypoglycaemia. Clin. Endocrinol. (Oxf.) 52: 781-787.
91. Galliven, E.A., A. Singh, D. Michelson, et al. 1997. Hormonal and metabolic responses to exercise across time of day and menstrual cycle phase. J. Appl. Physiol. 83: 1822-1831.
92. Altemus, M., C. Roca, E. Galliven, et al. 2001. Increased vasopressin and adrenocorticotropin responses to stress in the midluteal phase of the menstrual cycle. J. Clin. Endocrinol. Metab. 86: 2525-2530.
93. Roca, C.A., P.J. Schmidt, M. Altemus, et al. 2003. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J. Clin. Endocrinol. Metab. 88: 3057-3063.
94. Keller-Wood, M., J. Silbiger & C.E. Wood. 1988. Progesterone attenuates the inhibition of adrenocorticotropin responses by cortisol in nonpregnant ewes. Endocrinology 123: 647-651.
95. Turner, B.B. 1997. Influence of gonadal steroids on brain corticosteriod receptors: A minireview. Neurochem. Res. 22: 1375-1385.
96. Patchev, V.K. & O.F.X. Almeida. 1996. Gonadal steroids exert facilitating and "buffering" effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hormone and corticosteroid receptor genes in rat brain. J. Neurosci. 16: 7077-7084.
97. Young, E.A. 1995. The role of gonadal steroids in hypothalamic-pituitary- adrenal axis regulation. Crit. Rev. Neurobiol. 9: 371-381.
98. Smith, S.S., Q.H. Gong, F.-C. Hsu, et al. 1998. GABAA receptor alpha-4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392: 926-930.
99. Spruce, B.A., P.H. Baylis, J. Burd, et al. 1985. Variation in osmoregulation of arginine vasopressin during the human menstrual cycle. Clin. Endocrinol. 22: 37-42.
100. Ochedalski, T., S. Subburaju, P.C. Wynn, et al. 2007. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol. 19: 189-197.
101. Morgan,M.A.&D.W. Pfaff. 2002. Estrogen's effects on activity, anxiety and fear in two mouse strains. Behav. Brain Res. 132: 85-93.
102. Walf, A.A., M.E. Rhodes & C.A. Frye. 2004. Antidepressant effects of ERâ-selective estrogen receptor modulators in the forced swim test. Pharmacol. Biochem. Behav. 78: 523-529.
103. Rocha, B.A.,R. Fleischer, J.M. Schaeffer, et al. 2005. 17â-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-â knockout (BERKO) mice. Psychopharmacology 179: 637-643.
104. Walf, A.A. & C.A. Frye. 2005. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology 30: 1288-1301.
105. Estrada-Camarena, E., A. Fernandez-Guasti & C. Lopez-Rubalcava. 2006. Participation of the 5- HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test. Neuropsychopharmacology 31: 247-255.
106. 106. Estrada-Camarena, E., C. Lopez-Rubalcava & A. Fernandez-Guasti. 2006. Facilitating antidepressant-like actions of estrogens are mediated by 5-HT1A and estrogen receptors in the rat forced swimming test. Psychoneuroendocrinology 31: 905-914.
107. Lund, T.D., T. Rovis, W.C.J. Chung, et al. 2005. Novel actions of estrogen receptor-â on anxietyrelated behaviors. Endocrinology 146: 797-807.
108. Imwalle, D.B., J.-A. Gustafsson & E.F. Rissman. 2005. Lack of functional estrogen receptor â influences anxiety behavior and serotonin content in female mice. Physiol. Behav. 84: 157-163.
109. McKinlay, J.B., S.M. McKinlay & D. Brambilla. 1987. The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. J. Health Soc. Behav. 28: 345-363.
110. Kaufert, P.A., P. Gilbert & R. Tate. 1992. TheManitoba project: A re-examination of the link between menopause and depression. Maturitas 14: 143-155.
111. Avis,N.E.,D. Brambilla, S.M.McKinlay, et al. 1994. A longitudinal analysis of the association between menopause and depression: Results from the Massachusetts Women's Health Study. Ann. Epidemiol. 4: 214-220.
112. Matthews, K.A., R.R. Wing, L.H. Kuller, et al. 1990. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J. Consult. Clin. Psychol. 58: 345-351.
113. Holte, A. 1992. Influences of natural menopause on health complaints: A prospective study of healthy Norwegian women. Maturitas 14: 127-141.
114. Fugate Woods, N., A. Mariella & E. Sullivan Mitchell. 2002. Patterns of depressed mood across the menopausal transition: Approaches to studying patterns in longitudinal data. Acta Obstet. Gynecol. Scand. 81: 623-632.
115. Maartens, L.W.,G.L. Leusink, J.A. Knottnerus, et al. 2001. Climacteric complaints in the community. Fam. Pract. 18: 189-194.
116. den Tonkelaar, I., F.J. Broekmans, E.J. de Boer, et al. 2002. The stages of reproductive aging workshop. Letter to the Editor. Menopause 9: 463-464.
117. Hardy, R. & D. Kuh. 2002. Change in psychological and vasomotor symptom reporting during the menopause. Soc. Sci. Med. 55: 1975-1988.
118. Dennerstein, L., P. Lehert, H. Burger, et al. 1999. Mood and the menopausal transition. J. Nerv. Ment. Dis. 187: 685-691.
119. Weissman,M.M., P.J. Leaf,G.L.Tischler, et al. 1988. Affective disorders in five United States communities. Psychol. Med. 18: 141-153.
120. Kessler, R.C., K.A. McGonagle, M. Swartz, et al. 1993. Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 29: 85-96.
121. Hunter,M. 1992. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 14: 117-126.
122. O'Connor, V.M., C.B. Del Mar, M. Sheehan, et al. 1995. Do psycho-social factors contribute more to symptom reporting by middle-aged women than hormonal status? Maturitas 20: 63-69.
123. Bromberger, J.T., P.M. Meyer, H.M. Kravitz, et al. 2001. Psychologic distress and natural menopause: A multiethnic community study. Am. J. Public Health 91: 1435-1442.
124. Maartens, L.W.F., J.A. Knottnerus & V.J. Pop. 2002. Menopausal transition and increased depressive symptomatology: A community based prospective study. Maturitas 42: 195-200.
125. Bromberger, J.T., S.F. Assmann, N.E. Avis, et al. 2003. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am. J. Epidemiol. 158: 347-356.
126. Freeman, E.W., M.D. Sammel, L. Liu, et al. 2004. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch. Gen. Psychiatry 61: 62-70.
127. Stewart, D.E., K. Boydell, C. Derzko, et al. 1992. Psychologic distress during the menopausal years in women attending a menopause clinic. Int. J. Psychiatry Med. 22: 213-220.
128. Dennerstein, L., A.M.A. Smith, C. Morse, et al. 1993. Menopausal symptoms in Australian women. Med. J. Aust. 159: 232-236.
129. Hay, A.G., J. Bancroft & E.C. Johnstone. 1994. Affective symptoms in women attending a menopause clinic. Br. J. Psychiatry 164: 513-516.
130. Spitzer, R.L., J.B.W. Williams, K. Kroenke, et al. 1994. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. JAMA 272: 1749-1756.
131. Cohen, L.S., C.N. Soares, A.F. Vitonis, et al. 2006. Risk for new onset of depression during the menopausal transition. The Harvard study of moods and cycles. Arch. Gen. Psychiatry 63: 385-390.
132. Freeman, E.W., M.D. Sammel, H. Lin, et al. 2006. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch. Gen. Psychiatry 63: 375-382.
133. Bromberger, J.T., K.A.Matthews, L.L. Schott, et al. 2007. Depressive symptoms during the menopausal transition: The study of women's health across the nation (SWAN). J. Affect. Disord. 103: 267-272.
134. Bromberger, J.T., H.M. Kravitz, K.A. Matthews, et al. 2007. Predictors of first episodes of clinical depression in midlife women. Abstr. APA 160th Ann. Meeting 121.
135. 135.Schmidt, P.J., N.A. Haq & D.R. Rubinow. 2004. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am. J. Psychiatry 161: 2238-2244.
136. Steinberg, E.M., D.R. Rubinow, J.J. Bartko, et al. 2008. A cross sectional evaluation of perimenopausal depression. J. Clin. Psychiatry 69: 973-980.
137. Brambilla, F., M. Maggioni, E. Ferrari, et al. 1990. Tonic and dynamic gonadotropin secretion in depressive and normothymic phases of affective disorders. Psychiatry Res. 32: 229-239.
138. Amsterdam, J.D., A. Winokur, I. Lucki, et al. 1983. Neuroendocrine regulation in depressed postmenopausal women and healthy subjects. Acta Psychiatr. Scand. 67: 43-49.
139. Altman,N., E.J. Sachar, P.H.Gruen, et al. 1975. Reduced plasma LHconcentration in postmenopausal depressed women. Psychosom. Med. 37: 274-276.
140. Guicheney, P., D. Ĺeger, J. Barrat, et al. 1988. Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: Variations with plasma oestrogen levels and depressive symptoms. Eur. J. Clin. Invest. 18: 297-304.
141. Ballinger, S. 1990. Stress as a factor in lowered estrogen-levels in the early postmenopause. Ann. N. Y. Acad. Sci. 592: 95-113.
142. Huerta, R., A. Mena, J.M. Malacara, et al. 1995. Symptoms at perimenopausal period: Its association with attitudes toward sexuality, life-style, family function and FSH levels. Psychoneuroendocrinology 20: 135-148.
143. Saletu, B., N. Brandstatter, M. Metka, et al. 1996. Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls. Maturitas 23: 91-105.
144. Barrett-Connor, E.,D. von Muhlen,G.A. Laughlin, et al. 1999. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo study. J. Am. Geriatr. Soc. 47: 685-691.
145. Cawood, E.H. & J. Bancroft. 1996. Steroid hormones, the menopause, sexuality and well-being of women. Psychol. Med. 26: 925-936.
146. Schmidt, P.J., J.H. Murphy, N. Haq, et al. 2002. Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology 27: 907-920.
147. Majewska, M.D., S. Demirgören, C.E. Spivak, et al. 1990. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 526: 143-146.
148. Baulieu, E.-E.&P.Robel. 1998. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc. Natl. Acad. Sci. USA 95: 4089-4091.
149. Morales, A.J., J.J. Nolan, J.C. Nelson, et al. 1994. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78: 1360-1367.
150. Wolkowitz, O.M., V.I. Reus, A. Keebler, et al. 1999. Double-blind treatment of major depression with dehydroepiandrosterone. Am. J. Psychiatry 156: 646-649.
151. Bloch, M., P.J. Schmidt,M.A.Danaceau, et al. 1999. Dehydroepiandrosterone treatment of mid-life dysthymia. Biol. Psychiatry 45: 1533-1541.
152. Schmidt, P.J., R.C. Daly, M. Bloch, et al. 2005. Dehydroepiandrosterone monotherapy in midlifeonset major and minor depression. Arch. Gen. Psychiatry 62: 154-162.
153. Wolf, O.T., O. Neumann, D.H. Hellhammer, et al. 1997. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J. Clin. Endocrinol. Metab. 82: 2363-2367.
154. Laughlin, G.A. & E. Barrett-Connor. 2000. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: The Rancho Bernardo study. J. Clin. Endocrinol. Metab. 85: 3561-3568.
155. Ferrari, E., M. Locatelli, A. Arcaini, et al. 1997. Chronobiological study of some neuroendocrine features of major depression in elderly people. Abstr. 79th Annu. Meeting Endocr. Soc.
156. Daly, R.C., M.A. Danaceau, D.R. Rubinow, et al. 2003. Concordant restoration of ovarian function andmood in perimenopausal depression. Am. J. Psychiatry 160: 1842-1846.
157. Zweifel, J.E.&W.H.O'Brien. 1997.Ameta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22: 189-212.
158. Schmidt, P.J., L. Nieman, M.A. Danaceau, et al. 2000. Estrogen replacement in perimenopauserelated depression: A preliminary report. Am. J. Obstet. Gynecol. 183: 414-420.
159. Soares, C.D., O.P. Almeida, H. Joffe, et al. 2001. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Arch. Gen. Psychiatry 58: 529-534.
160. Morrison, M.F., M.J. Kallan, T. Ten Have, et al. 2004. Lack of efficacy of estradiol for depression in postmenopausal women: A randomized, controlled trial. Biol. Psychiatry 55: 406-412.
161. Montgomery, J.C., M. Brincat, A. Tapp, et al. 1987. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 329: 297-299.
162. Saletu, B., N. Brandstatter, M. Metka, et al. 1995. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology 122: 321-329.
163. Spitzer, R.L., K. Kroenke, M. Linzer, et al. 1995. Health-related quality of life in primary care patients with mental disorders: Results from the PRIME-MD 1000 study. JAMA 274: 1511-1517.
164. Warnock, J.K., J.C. Bundren & D.W. Morris. 1998. Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy. Biol. Psychiatry 43: 464-465.
165. Steingold, K.A., M. Cedars, J.K. Lu, et al. 1987. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. Obstet. Gynecol. 69: 403-411.
166. Harsh, V.L., P. Fortinsky, T.F. Gearhart, et al. 2008. Effects of induced hypogonadism on mood and behavior in healthywomen.Abstr. 161stAnn. Meeting APA.
167. Derogatis, L.R. 1997. The Derogatis interview for sexual functioning (DISF/DISF-SR): An introductory report. J. Sex Marital Ther. 23: 291-304.
168. Schmidt, P.J., E.M. Steinberg, P. Palladino Negro, et al. 2009. Pharmacologically-induced hypogonadism and sexual function in healthy young women and men. Neuropsychopharmacology 34: 565-576.
169. Radloff, L.S. 1977. The CES-D scale: A self-report depression scale for research in the general population. Appl. Psychol. Meas. 1: 385-401.